These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36577220)

  • 1. Development of novel S-N
    Ling X; Hao QQ; Huang WJ; Pannecouque C; De Clercq E; Wang S; Chen FE
    Eur J Med Chem; 2023 Feb; 247():115042. PubMed ID: 36577220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the S-CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase.
    Ling X; Hao QQ; Pannecouque C; Clercq E; Chen FE
    Eur J Med Chem; 2022 Aug; 238():114512. PubMed ID: 35679690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
    J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the DABOs family as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Yu M; Fan E; Wu J; Liu X
    Curr Med Chem; 2011; 18(16):2376-85. PubMed ID: 21568919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
    Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
    J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy.
    Sang YL; Pannecouque C; De Clercq E; Wang S; Chen FE
    J Med Chem; 2023 Apr; 66(7):4755-4767. PubMed ID: 36996328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.
    He Y; Chen F; Sun G; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3173-6. PubMed ID: 15149669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydro-alkoxyl-benzyl-oxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011).
    Yang S; Chen FE; De Clercq E
    Curr Med Chem; 2012; 19(2):152-62. PubMed ID: 22320294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
    Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M
    J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Discovery of Novel NH
    Jin X; Zhao LM; Wang S; Huang WJ; Zhang YX; Pannecouque C; De Clercq E; Chen FE
    J Med Chem; 2022 Jun; 65(12):8478-8492. PubMed ID: 35649164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.
    Wu HQ; Yan ZH; Chen WX; He QQ; Chen FE; De Clercq E; Balzarini J; Daelemans D; Pannecouque C
    Bioorg Med Chem; 2013 Nov; 21(21):6477-83. PubMed ID: 24055077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
    Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
    Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
    Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
    Vig R; Mao C; Venkatachalam TK; Tuel-Ahlgren L; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1461-6. PubMed ID: 9873370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Optimization of 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Exploiting the Tolerant Regions of the Non-Nucleoside Reverse Transcriptase Inhibitors' Binding Pocket.
    Zhao F; Zhang H; Xie M; Meng B; Liu N; Dun C; Qin Y; Gao S; De Clercq E; Pannecouque C; Tang YJ; Zhan P; Liu X; Kang D
    J Med Chem; 2023 Feb; 66(3):2102-2115. PubMed ID: 36700940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase.
    Costi R; Di Santo R; Artico M; Massa S; Lavecchia A; Marceddu T; Sanna L; La Colla P; Marongiu ME
    Antivir Chem Chemother; 2000 Mar; 11(2):117-33. PubMed ID: 10819436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.